BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 19318043)

  • 1. New approaches to pharmacotherapy of tumors of the nervous system during childhood and adolescence.
    Schor NF
    Pharmacol Ther; 2009 Apr; 122(1):44-55. PubMed ID: 19318043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy for adults with tumors of the central nervous system.
    Schor NF
    Pharmacol Ther; 2009 Mar; 121(3):253-64. PubMed ID: 19091301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric high-grade glioma: molecular genetic clues for innovative therapeutic approaches.
    Rood BR; MacDonald TJ
    J Neurooncol; 2005 Dec; 75(3):267-72. PubMed ID: 16195804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successive double high-dose chemotherapy with peripheral blood stem cell rescue collected during a single leukapheresis round in patients with high-risk pediatric solid tumors: a pilot study in a single center.
    Sung KW; Yoo KH; Chung EH; Jung HL; Koo HH; Shin HJ; Lee SK; Lim DH; Kim DW; Park HK; Cho EJ; Kim SW
    Bone Marrow Transplant; 2003 Mar; 31(6):447-52. PubMed ID: 12665839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival after second primary neoplasms of the brain or spinal cord in survivors of childhood cancer: results from the British Childhood Cancer Survivor Study.
    Taylor AJ; Frobisher C; Ellison DW; Reulen RC; Winter DL; Taylor RE; Stiller CA; Lancashire ER; Tudor EC; Baggott C; May S; Hawkins MM
    J Clin Oncol; 2009 Dec; 27(34):5781-7. PubMed ID: 19786666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Malignant solid tumors in neonates: a study of 71 cases].
    de Bouyn-Icher C; Minard-Colin V; Isapof A; Khuong Quang DA; Redon I; Hartmann O
    Arch Pediatr; 2006 Dec; 13(12):1486-94. PubMed ID: 17137765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
    Thorarinsdottir HK; Rood B; Kamani N; Lafond D; Perez-Albuerne E; Loechelt B; Packer RJ; MacDonald TJ
    Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting hyaluronan interactions in spinal cord astrocytomas and diffuse pontine gliomas.
    Maria BL; Gupta N; Gilg AG; Abdel-Wahab M; Leonard AP; Slomiany M; Wheeler WG; Tolliver LB; Babcock MA; Lucas JT; Toole BP
    J Child Neurol; 2008 Oct; 23(10):1214-20. PubMed ID: 18952588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes and late endocrine, neurocognitive, and visual profiles of proton radiation for pediatric low-grade gliomas.
    Greenberger BA; Pulsifer MB; Ebb DH; MacDonald SM; Jones RM; Butler WE; Huang MS; Marcus KJ; Oberg JA; Tarbell NJ; Yock TI
    Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1060-1068. PubMed ID: 25035209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic management of high-risk neuroblastoma in children.
    Ganeshan VR; Schor NF
    Paediatr Drugs; 2011 Aug; 13(4):245-55. PubMed ID: 21692548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New treatment strategies for malignant gliomas.
    Sathornsumetee S; Rich JN
    Expert Rev Anticancer Ther; 2006 Jul; 6(7):1087-104. PubMed ID: 16831080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of initial CNS involvement in acute lymphoblastic leukemia childhood.
    Dörffel W; Zintl F; Malke H; Reuter G; Reimann M
    Haematol Blood Transfus; 1990; 33():494-9. PubMed ID: 2182443
    [No Abstract]   [Full Text] [Related]  

  • 13. Malignant gliomas.
    Wen PY; Kesari S
    Curr Neurol Neurosci Rep; 2004 May; 4(3):218-27. PubMed ID: 15102348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of pediatric brain tumors.
    Packer RJ
    Curr Opin Neurol; 1994 Dec; 7(6):484-91. PubMed ID: 7866579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reevaluation of procarbazine for the treatment of recurrent malignant central nervous system tumors.
    Rodriguez LA; Prados M; Silver P; Levin VA
    Cancer; 1989 Dec; 64(12):2420-3. PubMed ID: 2555038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposing the defenses of gliomas.
    Heimer H
    J Natl Cancer Inst; 1997 Nov; 89(22):1662. PubMed ID: 9390533
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotherapy for malignant gliomas.
    Forsyth PA; Cairncross JG
    Baillieres Clin Neurol; 1996 Jun; 5(2):371-93. PubMed ID: 8781278
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of recurrent brain stem gliomas and other central nervous system tumors with 5-fluorouracil, CCNU, hydroxyurea, and 6-mercaptopurine.
    Rodriguez LA; Prados M; Fulton D; Edwards MS; Silver P; Levin V
    Neurosurgery; 1988 Apr; 22(4):691-3. PubMed ID: 3374780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second neoplasms in pediatric patients with primary central nervous system tumors: the St. Jude Children's Research Hospital experience.
    Broniscer A; Ke W; Fuller CE; Wu J; Gajjar A; Kun LE
    Cancer; 2004 May; 100(10):2246-52. PubMed ID: 15139071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A survey of tumors of the central nervous system in Iceland during the 10-year period 1954-1963.
    Guomundsson KR
    Acta Neurol Scand; 1970; 46(4):538-52. PubMed ID: 4323342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.